Yifan Mao

611 citations
39 papers · 389 indexed · h-index 11
Topics
Extracellular vesicles in disease (6 papers)Thyroid Cancer Diagnosis and Treatment (4 papers)Global Cancer Incidence and Screening (3 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Yifan Mao

29 papers receiving 384 citations

Peers

Yifan Mao
Comparison fields: 5 of 71
  • Molecular Biology 242
  • Cancer Research 61
  • Surgery 52
  • Oncology 46
  • Physiology 40
Replace Jessica Bonneau with:
Jessica Bonneau France
Nicole Hannemann Germany
Koji Takasugi Japan
Takeaki Inomoto Japan
Xingang Zhou China
Eric G. Ramírez-Salazar Mexico
Hong Yuan China
Riccardo Terenzi Italy
Andriy O. Samokhin United States
B. W. Kirkham Australia
Yifan Mao relative to Jessica Bonneau France Jessica Bonneau's profile →
Citations per field
00.5×3.7×
Jessica Bonneau · 1×
Citations per year

Countries citing papers authored by Yifan Mao

Since Specialization
Citations

This map shows the geographic impact of Yifan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifan Mao more than expected).

Fields of papers citing papers by Yifan Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifan Mao. The network helps show where Yifan Mao may publish in the future.

Co-authorship network of co-authors of Yifan Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Yifan Mao. A scholar is included among the top collaborators of Yifan Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifan Mao. Yifan Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 0
6 1
7 2
8 1
9 2
10 3
11 9
12 12
13 1
14 5
15 9
16 21
17 2
18 20
19 40
20 39

About Yifan Mao

Yifan Mao is a scholar working on Orthopedics and Sports Medicine, Pharmacy and Biological Psychiatry, having authored 39 papers that have together received 389 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (6 papers), Thyroid Cancer Diagnosis and Treatment (4 papers) and Global Cancer Incidence and Screening (3 papers). The work is most often cited by research in Cancer Research (61 citations), Orthopedics and Sports Medicine (32 citations) and Molecular Biology (242 citations). Yifan Mao has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Liya Zhang, Yuan Li, Victoria C. Pham, Jiping Zha, Jennie R. Lill, Jian Wu, Mark J. Solloway, Sebastián Guelman, John Wang and Kenji Kozuka. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026